Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Systems Microbiology
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1422132

A Mendelian randomization analysis reveals a multifaceted role of skin microbiota in Liver cancer

Provisionally accepted
  • 1 Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
  • 2 Department of Surgical Oncology, The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

The final, formatted version of the article will be published soon.

    Background: Hepatocellular carcinoma (HCC, or Hepatic cancer, HC) and Cholangiocarcinoma (CCA, or Hepatic bile duct cancer, HBDC) are two major types of primary liver cancer (PLC). Previous studies have suggested microbiota can act as risk factors or preventive factors in PLC. However, no study reported the relationship between skin microbiota and PLC. Therefore, we employed a two-sample Mendelian randomization (MR) study to assess the causality between skin microbiota and PLC.The skin microbiota association genome-wide association study (GWAS) data were collected. The GWAS summary data for GCST90018803 (Hepatic bile duct cancer, HBDC) and GCST90018858 (Hepatic cancer, HC) were utilized in the discovery and verification phases, respectively. The inverse variance weighted (IVW) method was utilized as the principal method in our Mendelian randomization (MR) study. The MR-Egger intercept test, Cochran's Q test, MR-Pleiotropy RESidual Sum and Outlier (MR-PRESSO) and leave-oneout analysis were conducted to identify the heterogeneity and pleiotropy.The results showed that Veillonella (unc.) plays a protective role in HBDC, family: neisseriaceae has a positive association with HBDC risk. Class: betaproteobacteria, phylum: bacillota (firmicutes) and Veillonella (unc.) play a protective role in HC, S. epidermidis, Corynebacterium (unc.), family: neisseriaceae, Pasteurellaceae sp. were associated with an increased risk in HC.This study provided new evidence of the association between skin microbiota and PLC, suggesting that skin microbiota plays a role in PLC progression. Skin microbiota could be a novel and effective way for PLC diagnosis and treatment.

    Keywords: Causal impact, European descent, liver cancer, Mendelian randomization, skin microbiota.

    Received: 23 Apr 2024; Accepted: 03 Jul 2024.

    Copyright: © 2024 Wang and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Zexin Zhu, Department of Surgical Oncology, The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.